ÂÜÀòÂÒÂ×

Dr. Roy Duncan is renowned for discovering the Fusion Associated Small Transmembrane (FAST) protein family, a critical component of the Fusogenix technology. He has spent many years studying viral fusion proteins as a Professor and Killam Chair at Dalhousie University. Roy is also deeply involved in the COVID-19 vaccine development. For nearly 30 years, Dr. Duncan’s research has been continuously funded by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC). He currently holds a prestigious 7-year CIHR Foundation Grant.